Clinical Trials
354 trialsNeoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
ctDNA
Institute of Oncology Ljubljana
dOCT-pBCC
Vejle Hospital
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Mechanisms for Laser-Induced Rejuvenation
Wright State University
CARES
Universitaire Ziekenhuizen KU Leuven
Cryoablation+Ipilimumab+Nivolumab in Melanoma
Massachusetts General Hospital
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
Memorial Sloan Kettering Cancer Center
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
LANCE
Jules Bordet Institute
Suzetrigine vs Norco-postoperative Mohs Pain
Baylor Research Institute
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
Raman Spectroscopy and Skin Cancer
Stony Brook University
Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery
Memorial Sloan Kettering Cancer Center
iCaRe2
University of Nebraska
Skin Cancer Diagnostics Using Photoacoustic Imaging
Region Skane
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Cancer Prevention & Online Technologies
Stanford University
NeoMatryx
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
THERMS
Universitaire Ziekenhuizen KU Leuven
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
STARS
University of Utah
ICARUS
University of Thessaly
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
H. Lee Moffitt Cancer Center and Research Institute
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
Fred Hutchinson Cancer Center
ctDNA in Cutaneous Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
University of Southern California
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Pilot Trial of Supplemental Vitamin A and Nicotinamide
Rhode Island Hospital
BCC-One-Stop-Study
University Hospital Augsburg
ELEPHAS-04
Mayo Clinic
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
CEMI-first
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
Case Comprehensive Cancer Center
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
H. Lee Moffitt Cancer Center and Research Institute
MAK
Institute of Oncology Ljubljana
Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry
West Virginia University
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
H. Lee Moffitt Cancer Center and Research Institute
The Florida ASCENT Study
University of Florida
MAK
Institute of Oncology Ljubljana
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
Institute of Oncology Ljubljana
TIL Therapy in cSCC and MCC
Dana-Farber Cancer Institute
OpticSkin
Centre Hospitalier Régional Metz-Thionville
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
Mayo Clinic